GILD:NGS-Gilead Sciences Inc. (USD)

EQUITY | Drug Manufacturers - General | Nasdaq Global Select

Last Closing

USD 109.09

Change

+1.72 (+1.60)%

Market Cap

USD 98.10B

Volume

7.93M

Analyst Target

USD 77.75
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-27 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
AZN AstraZeneca PLC ADR

+0.49 (+0.70%)

USD 218.30B
AMGN Amgen Inc

+5.14 (+1.85%)

USD 151.21B
SNY Sanofi ADR

+0.36 (+0.69%)

USD 126.38B
BIIB Biogen Inc

+5.22 (+4.09%)

USD 17.35B
GRFS Grifols SA ADR

+0.18 (+2.20%)

USD 5.91B
AMRN Amarin Corporation PLC

+0.39 (+3.45%)

USD 0.23B
MIRA MIRA Pharmaceuticals, Inc. Com..

N/A

USD 0.02B
SCLX Scilex Holding Company

+0.40 (+7.62%)

N/A
SCLXW Scilex Holding Company

-0.01 (-12.33%)

N/A

ETFs Containing GILD

BTEC:SW iShares Nasdaq US Biotech.. 8.25 % 0.00 %

N/A

N/A
UBIO 7.77 % 0.95 %

N/A

N/A
UDI USCF ETF Trust 4.00 % 0.00 %

+0.13 (+0.22%)

N/A
JPHG:PA Amundi Index Solutions - .. 3.90 % 0.00 %

-0.55 (0.22%)

N/A
JPHC:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 4.62M
JPHE:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.06B
JPHG:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 3.59M
JPHU:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.06B
JPNK:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.07B
JPNY:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 6.26B
MOAT:AU VanEck Morningstar Wide M.. 3.41 % 0.00 %

+1.53 (+0.22%)

USD 1.04B
CBUF:F iShares V Public Limited .. 3.37 % 0.00 %

-0.01 (0.22%)

N/A
MDLV EA Series Trust - Morgan .. 3.19 % 0.00 %

+0.11 (+0.22%)

N/A
WHCS:SW iShares MSCI World Health.. 3.19 % 0.00 %

N/A

N/A
LGCF Themes US Cash Flow Champ.. 3.10 % 0.00 %

+0.07 (+0.22%)

N/A
QQQG Pacer Nasdaq 100 Top 50 C.. 2.90 % 0.00 %

-0.12 (0.22%)

USD 3.61M
HEAL:SW iShares Healthcare Innova.. 2.66 % 0.00 %

N/A

USD 1.05B
ABFL Abacus FCF Leaders ETF 2.64 % 0.00 %

-0.18 (0.22%)

N/A
WMOT:XETRA VanEck Morningstar US Wid.. 2.51 % 0.00 %

-0.06 (0.22%)

N/A
CURE:AU ETFS S&P Biotech ETF 2.44 % 0.00 %

+0.98 (+0.22%)

USD 0.04B
ZYUS:AU ANZ S&P 500 High Yield Lo.. 2.38 % 0.00 %

-0.02 (0.22%)

USD 0.08B
DHS:SW 2.04 % 0.00 %

N/A

N/A
DHSA:SW 2.04 % 0.00 %

N/A

N/A
RAYD Rayliant Quantitative Dev.. 1.98 % 0.00 %

-0.21 (0.22%)

USD 0.09B
CBUI:XETRA iShares MSCI World Value .. 1.88 % 0.00 %

-0.03 (0.22%)

USD 0.26B
INCM:AU BetaShares Global Income .. 1.80 % 0.00 %

+0.03 (+0.22%)

USD 0.03B
IQSA:LSE Invesco Quantitative Stra.. 1.74 % 0.00 %

N/A

USD 0.75B
ESMV iShares ESG MSCI USA Min .. 1.73 % 0.00 %

+0.06 (+0.22%)

USD 8.52M
MVEW:SW iShares Edge MSCI World M.. 1.65 % 0.00 %

N/A

USD 0.50B
MVWE:SW iShares Edge MSCI World M.. 1.65 % 0.00 %

N/A

USD 0.07B
MVEA:SW iShares Edge MSCI USA Min.. 1.60 % 0.00 %

N/A

USD 0.26B
MVEA:LSE iShares Edge MSCI USA Min.. 1.58 % 0.00 %

-0.03 (0.22%)

N/A
MVEC:SW iShares Edge MSCI World M.. 1.55 % 0.00 %

N/A

USD 0.17B
MVEW:LSE iShares Edge MSCI World M.. 1.53 % 0.00 %

-0.03 (0.22%)

USD 0.50B
WDMVO:SW 1.50 % 0.00 %

N/A

N/A
DGVA:AU Dimensional Global Value .. 1.03 % 0.00 %

+0.05 (+0.22%)

N/A
EVO:CA Evovest Global Equity ETF 0.96 % 0.00 %

-0.17 (0.22%)

N/A
WELE:XETRA Amundi S&P 500 Equal Weig.. 0.59 % 0.00 %

-0.10 (0.22%)

N/A
XDEW:SW 0.25 % 0.00 %

N/A

N/A
BBH VanEck Biotech ETF 0.00 % 0.35 %

+2.26 (+0.22%)

USD 0.34B
BBP Virtus LifeSci Biotech Pr.. 0.00 % 0.79 %

+1.29 (+0.22%)

USD 0.02B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

+1.84 (+0.22%)

USD 0.05B
BIS ProShares UltraShort Nasd.. 0.00 % 0.95 %

-0.75 (0.22%)

USD 3.16M
BSCK 0.00 % 0.10 %

N/A

N/A
BSCL 0.00 % 0.10 %

N/A

N/A
BSCQ Invesco BulletShares 2026.. 0.00 % 0.10 %

+0.01 (+0.22%)

N/A
CBND 0.00 % 0.16 %

N/A

N/A
DVP Roundhill Acquirers Deep .. 0.00 % 0.48 %

N/A

N/A
ESGW 0.00 % 0.40 %

N/A

N/A
FCY 0.00 % 0.84 %

N/A

N/A
FCY:CA 0.00 % 0.95 %

N/A

N/A
FDL First Trust Morningstar D.. 0.00 % 0.45 %

+0.27 (+0.22%)

N/A
FLAG Global X Funds 0.00 % 1.52 %

+0.03 (+0.22%)

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

+2.33 (+0.22%)

USD 5.43B
IBCD 0.00 % 0.10 %

N/A

N/A
LABU Direxion Daily S&P Biotec.. 0.00 % 1.14 %

+3.31 (+0.22%)

USD 0.54B
MOAT VanEck Morningstar Wide M.. 0.00 % 0.49 %

+0.86 (+0.22%)

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

+0.35 (+0.22%)

N/A
ONEY SPDR® Russell 1000® Yie.. 0.00 % 0.20 %

+0.45 (+0.22%)

N/A
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

+0.79 (+0.22%)

N/A
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

+0.32 (+0.22%)

USD 0.01B
IVFVC 0.00 % 0.00 %

N/A

N/A
VSL 0.00 % 0.65 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

+0.05 (+0.22%)

CAD 0.10B
ZFN:CA BMO SIA Focused North Ame.. 0.00 % 0.00 %

-0.32 (0.22%)

CAD 0.30B
JIGB 0.00 % 0.14 %

N/A

N/A
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
SPBO SPDR Portfolio Corporate .. 0.00 % 0.00 %

+0.11 (+0.22%)

USD 1.53B
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.07 (+0.22%)

N/A
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.05 (+0.22%)

N/A
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.08 (+0.22%)

N/A
RJZ 0.00 % 0.75 %

N/A

N/A
SCIU 0.00 % 0.19 %

N/A

N/A
SICK 0.00 % 0.95 %

N/A

N/A
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

+1.69 (+0.22%)

N/A
XMS:CA iShares Edge MSCI Min Vol.. 0.00 % 0.33 %

+0.02 (+0.22%)

N/A
ZBIO Zenas BioPharma, Inc. Com.. 0.00 % 0.95 %

+0.77 (+0.22%)

N/A
FCW:CA 0.00 % 0.90 %

N/A

N/A
SPDV AAM S&P 500 High Dividend.. 0.00 % 0.29 %

-0.09 (0.22%)

USD 0.07B
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

-4.50 (0.22%)

N/A
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

-0.02 (0.22%)

N/A
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

-0.01 (0.22%)

N/A
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

-0.50 (0.22%)

N/A
DHSP:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

-4.50 (0.22%)

N/A
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

+3.25 (+0.22%)

N/A
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

+0.04 (+0.22%)

N/A
MINV:LSE iShares VI Public Limited.. 0.00 % 0.00 %

-20.00 (0.22%)

N/A
MVOL:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

-0.09 (0.22%)

N/A
XFVT:LSE Xtrackers FTSE Vietnam Sw.. 0.00 % 0.00 %

-55.75 (0.22%)

N/A
JPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

-0.25 (0.22%)

USD 4.64M
UBBB:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.23 (+0.22%)

USD 0.13B
2B70:F iShares NASDAQ US Biotech.. 0.00 % 0.00 %

N/A

USD 0.52B
JP40:F Amundi Index Solutions - .. 0.00 % 0.00 %

-0.82 (0.22%)

N/A
JP4H:F 0.00 % 0.00 %

N/A

N/A
WTD9:F WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

USD 0.06B
WTDY:F WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

+0.05 (+0.22%)

USD 1.08M
WTEU:F WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.13 (+0.22%)

USD 0.11B
2B70:XETRA iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.04 (+0.22%)

USD 0.52B
2B78:XETRA iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

USD 1.05B
JP40:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

-0.12 (0.22%)

N/A
JP4H:XETRA 0.00 % 0.00 %

N/A

N/A
WTD9:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

-0.22 (0.22%)

N/A
WTDY:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

-0.03 (0.22%)

N/A
WTEU:XETRA WisdomTree US Equity Inco.. 0.00 % 0.00 %

-0.18 (0.22%)

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
ZINN:CA 0.00 % 0.00 %

N/A

N/A
AFLG First Trust Active Factor.. 0.00 % 0.00 %

+0.08 (+0.22%)

USD 0.26B
HDLB ETRACS Monthly Pay 2xLeve.. 0.00 % 0.00 %

+0.24 (+0.22%)

USD 8.97M
JPGL:XETRA JPM Global Equity Multi-F.. 0.00 % 0.00 %

-0.39 (0.22%)

N/A
MVEW:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

-0.05 (0.22%)

N/A
SCHJ Schwab 1-5 Year Corporate.. 0.00 % 0.00 %

+0.03 (+0.22%)

N/A
FLSP Franklin Liberty Systemat.. 0.00 % 0.00 %

-0.10 (0.22%)

USD 0.34B
HDIV 0.00 % 0.00 %

N/A

N/A
KVLE KFA Value Line Dynamic Co.. 0.00 % 0.00 %

+0.08 (+0.22%)

USD 0.01B
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

-0.01 (0.22%)

N/A
IBBQ Invesco Nasdaq Biotechnol.. 0.00 % 0.00 %

+0.38 (+0.22%)

USD 0.04B
2B78:F iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
JPGL:F JPmorgan ETFs Ireland Ica.. 0.00 % 0.00 %

-0.38 (0.22%)

N/A
CSY9:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

-0.94 (0.22%)

USD 0.29B
TSWE:SW VanEck Sustainable World .. 0.00 % 0.00 %

N/A

USD 0.93B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.10% 90% A- 85% B
Dividend Return 0.86% 25% F 47% F
Total Return 18.96% 90% A- 85% B
Trailing 12 Months  
Capital Gain 70.61% 90% A- 91% A-
Dividend Return 4.85% 100% F 79% B-
Total Return 75.46% 90% A- 92% A
Trailing 5 Years  
Capital Gain 44.84% 86% B+ 64% D
Dividend Return 19.48% 80% B- 61% D-
Total Return 64.31% 86% B+ 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 5.72% 70% C- 59% D-
Dividend Return 9.35% 70% C- 63% D
Total Return 3.63% 80% B- 74% C
Risk Return Profile  
Volatility (Standard Deviation) 28.06% 50% F 63% D
Risk Adjusted Return 33.34% 70% C- 68% D+
Market Capitalization 98.10B 63% D 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers - General) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 7.00 71% 44%
Price/Book Ratio 6.38 38% 19%
Price / Cash Flow Ratio 11.29 50% 26%
Price/Free Cash Flow Ratio 13.16 38% 29%
Management Effectiveness  
Return on Equity 32.65% 88% 95%
Return on Invested Capital 3.09% 38% 62%
Return on Assets 12.00% 100% 96%
Debt to Equity Ratio 128.79% 50% 16%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.